Last updated on February 2018

Efficacy Safety And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy


Brief description of study

The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy.

Clinical Study Identifier: NCT01846663

Find a site near you

Start Over

McGuire VA Medical Center

Richmond, VA United States
  Connect »

Banner Research

Phoenix, AZ United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

Salix Site

New Haven, CT United States
  Connect »

Salix Site

Tampa, FL United States
  Connect »

Piedmont Atlanta Hospital

Atlanta, GA United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Salix Site

Portland, OR United States
  Connect »

Brook Army Medical Center

Fort Sam Houston, TX United States
  Connect »

Salix Site

Galveston, TX United States
  Connect »

The Methodist Hospital

Houston, TX United States
  Connect »

VCU/MCV Health Systems

Richmond, VA United States
  Connect »

Swedish Medical Center

Seattle, WA United States
  Connect »